PO12 | Characterisation and real word clinical data of HEM006, a newly formulated intranasal spray desmopressin (DDAVP) to address a global treatment gap
Background and Aims: Desmopressin acetate (DDAVP) intranasal spray has been a cornerstone treatment for over three decades in managing bleeding episodes and surgical prophylaxis in patients with von Willebrand disease (VWD) type 1 and non-severe hemophilia A. A recent meta-analysis (>70 studies,...
Saved in:
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
PAGEPress Publications
2025-07-01
|
| Series: | Bleeding, Thrombosis and Vascular Biology |
| Subjects: | |
| Online Access: | https://www.btvb.org/btvb/article/view/274 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|